By Adriano Marchese
PharmaCielo Ltd. said Monday that it has received its first commercial order for its active pharmaceutical ingredient from a Brazil-based pharmaceutical company.
PharmaCielo, a Canadian medical cannabis products company, received the order from Ease Labs Pharma to provide regular shipments of canabidiol isolates as an active pharmaceutical ingredient starting in February.
Ease Labs received regulatory approval from the Brazilian Health Regulatory Agency to launch its canabidiol product in the country, and PharmaCielo's proprietary ingredient was included as part of the approval.
PharmaCielo didn't release any financial details of the agreement.
Write to Adriano Marchese at adriano.marchese@wsj.com
PharmaCielo Secures Commercial Order for Active Pharmaceutical Ingredient in Brazil - MarketWatch
Read More
No comments:
Post a Comment